Professor Ros Eeles is a leading expert in the field of cancer genetics and currently runs a research programme at The ICR on genetic predisposition to prostate cancer and management of individuals with BRCA mutations. She leads several large international consortia conducting research in genetic predisposition to prostate cancer and has authored over 313 papers. She is Co-PI on the ICGC – prostate cancer initiative in the UK.
Having studied at the University of Cambridge and St Thomas’ Hospital Medical School, she went on to train in Clinical Oncology at The Royal Marsden. Her research training was in genetic predisposition to cancer at The ICR and The University of Utah, USA, and she has a PhD in Cancer Genetics from the University of London.
Professor Eeles is accredited in Clinical Oncology with a sub-specialism in cancer genetics – cancer risk assessment, genetic testing for predisposition to cancer, targeted screening advice based on cancer genetic risk assessment and the application of cancer genetics to cancer care.
She has sat on several genetics advisory committees, including the Department of Health Genetics Advisory Committee, has given evidence to the House of Lords’ Select Committee on genomic medicine and edited a special edition of the Familial Cancer journal on delivery of cancer genetics services.
Professor Eeles is a Fellow of the Royal College of Physicians of London, a Fellow of the Royal College of Radiologists (Clinical Oncology Faculty), and Fellow of the Academy of Medical Sciences, UK.